innovations in mds and aml treatment
Published 4 years ago • 253 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
0:55
the role of rna modifications in mds and aml
-
1:09
differences and similarities between mds and aml & how this can inform treatment decisions
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
1:41
the future of aml and mds diagnosis and treatment
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:11
the treatment of aml within the united kingdom nhs framework
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:43
novel therapies in the future of mds treatment
-
7:46
updates in aml treatment and research from asco 2023
-
14:43
current research into post-allosct maintenance therapy in aml
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:41
an overview of the mds diagnosis pathway
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:08
approved and emerging treatment options for transplant-ineligible patients with high-risk mds
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:09
advances in the management of fit adults with aml
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
2:58
feasibility and safety of early discharge in nd aml following intensive induction therapy
-
1:16
state of the art: mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
2:16
current and future treatment approaches for hr-mds